v3.25.1
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Unaudited) - CAD ($)
Issued capital [member]
Reserve of share-based payments [member]
Warrant reserve [member]
Retained earnings [member]
Reserve of gains and losses from investments in equity instruments [member]
Reserve of exchange differences on translation [member]
Total
Balance at Dec. 31, 2023 $ 97,070,976 $ 6,870,139 $ (103,588,356) $ (434,303) $ 489,260 $ 407,716
Balance, shares at Dec. 31, 2023 1,969,566            
IfrsStatementLineItems [Line Items]              
Shares issued for financing $ 2,017,966 2,017,966
Shares issued for financing, shares 448,000            
Share issue costs $ (338,836) 72,185 (266,651)
Shares issued for the exercise of warrant $ 1,205,005 1,205,005
Shares issued for exercise of warrant, shares 152,000            
Shares issued for the exercise of RSUs $ 68,751 (68,751)
Shares issued for the exercise of RSUs, shares 2,547            
Share-based payments 198,907 198,907
Shares returned to treasury
Shares returned to treasury, shares (36,000)            
Net loss (1,863,808) (1,863,808)
Change in fair value of equity investments at FVOCI (11,046) (11,046)
Translation of foreign operations (9,562) (9,562)
Balance at Mar. 31, 2024 $ 100,023,862 7,072,480 (105,452,164) (445,349) 479,698 1,678,527
Balance, shares at Mar. 31, 2024 2,536,113            
Balance at Dec. 31, 2023 $ 97,070,976 6,870,139 (103,588,356) (434,303) 489,260 407,716
Balance, shares at Dec. 31, 2023 1,969,566            
IfrsStatementLineItems [Line Items]              
Shares returned to treasury, shares (36,000)            
Balance at Dec. 31, 2024 $ 110,742,984 7,698,304 3,776,428 (117,465,829) (609,420) 479,316 4,621,783
Balance, shares at Dec. 31, 2024 5,427,795            
Balance at Mar. 31, 2024 $ 100,023,862 7,072,480 (105,452,164) (445,349) 479,698 1,678,527
Balance, shares at Mar. 31, 2024 2,536,113            
IfrsStatementLineItems [Line Items]              
Shares issued for financing $ 8,366,179 8,366,179
Shares issued for financing, shares 1,029,208            
Share issue costs $ (1,294,035) 437,269       (856,766)
Shares issued for the exercise of warrant $ 2,851,822 2,851,822
Shares issued for exercise of warrant, shares 1,839,668            
Shares issued for the exercise of RSUs $ 795,156 (795,156)
Shares issued for the exercise of RSUs, shares 22,806            
Share-based payments 983,711 983,711
Net loss (12,013,665) (12,013,665)
Change in fair value of equity investments at FVOCI (164,071) (164,071)
Translation of foreign operations (382) (382)
Warrants – equity treatment 3,776,428 3,776,428
Balance at Dec. 31, 2024 $ 110,742,984 7,698,304 3,776,428 (117,465,829) (609,420) 479,316 4,621,783
Balance, shares at Dec. 31, 2024 5,427,795            
IfrsStatementLineItems [Line Items]              
Share issue costs $ (306) (306)
Shares issued for the exercise of RSUs $ 480,100 (480,100)
Shares issued for the exercise of RSUs, shares 6,029            
Share-based payments 288,883 288,883
Net loss (3,424,825) (3,424,825)
Change in fair value of equity investments at FVOCI 7,173 7,173
Translation of foreign operations (16,060) (16,060)
Balance at Mar. 31, 2025 $ 111,222,778 $ 7,507,087 $ 3,776,428 $ (120,890,654) $ (602,247) $ 463,256 $ 1,476,648
Balance, shares at Mar. 31, 2025 5,433,824